TITLE

Acid Hyperphenylphosphatasia in Thrombophlebitis and Pulmonary Embolism

AUTHOR(S)
Schoenfeld, Myron R.; Lepow, Harold; Woll, Fanya; Edis, Gloria
PUB. DATE
September 1962
SOURCE
Annals of Internal Medicine;Sep62, Vol. 57 Issue 3, p468
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines acid hyperphenylphosphatasia in thrombophlebitis and pulmonary embolism. Measurement of acid phenylphosphatase activity; Diagnosis of thrombophlebitis; Case reports on the occurrence of the disease in several patients.
ACCESSION #
7032082

 

Related Articles

  • Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an evidence-based approach to a clinical problem. Hill, Andrew B.; Garber, Brian; Dervin, Geoffrey; Howard, Andrew // Canadian Journal of Surgery;Aug2002, Vol. 45 Issue 4, p282 

    Examines the efficacy of heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries. Decrease of pulmonary embolism; Reduction of phlebitis and trauma; Elimination of external injuries.

  • Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients.  // BMJ: British Medical Journal (International Edition);1/22/94, Vol. 308 Issue 6923, p234 

    Examines the efficacy of antiplatelet therapy as prophylaxis against deep venous thrombosis (DVT) and pulmonary embolism in surgical and high risk patients. Reduction in DVT; Evidence of greater effect in combination with other forms of thromboprophylaxis; Effect of antiplatelet therapy pm...

  • Q/Do endovascular filters prevent PE as effectively as anti-coagulants in patients with DVT? Flaim, Allison; Brennan, Michal; Safranek, Sarah // Journal of Family Practice; 

    The article provides an answer to a question about the effectiveness of endovascular filters in preventing pulmonary embolism to patients with deep venous thrombosis (DVT).

  • Improving survival in pulmonary embolism. Saunders, Carol S. // Patient Care;8/30/2000, Vol. 34 Issue 16, p50 

    Discusses the diagnosis and treatment of pulmonary embolism, according to guidelines issues by the American Thoracic Society and the American College of Chest Physicians. Risk factors; Symptoms and signs; Initial investigations; Increased dependence on spiral computed tomography; Standard...

  • Vascular viewpoint. Anand, S.S. // Vascular Medicine;2001, Vol. 6 Issue 4, p269 

    Question: Is anticoagulant treatment for calf vein thrombosis for 6 weeks duration associated with acceptable recurrence and safety outcomes? Is anticoagulant therapy for 3 months duration for proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) associated with acceptable recurrence...

  • Preventing Deep Venous Thrombosis in Hospitalized Patients. King, Mitchell S. // American Family Physician;5/1/1994, Vol. 49 Issue 6, p1389 

    Presents information on how to prevent pulmonary embolism by preventing the occurrence of deep venous thrombosis. Predisposing factors involved; Effectiveness of various prophylactic treatments; Risk of hemorrhagic complications in the perioperative period; Cost-effectiveness of prophylactic...

  • Acute Venous Thromboembolism: Diagnostic Guidelines. Tapson, Victor // American Family Physician;11/15/2000, Vol. 62 Issue 10, p2226 

    Editorial. Provides diagnostic guidelines for deep venous thrombosis (DVT). Information on pulmonary embolism (PE); Importance of monitoring risk factors to DVT and PE; Discussion on the diagnostic approaches to suspected patients.

  • Pulmonary Talc Granulomatosis Masquerading as Massive Pulmonary Embolism. Agarwal, Archana M.; Grey, Todd C. // International Journal of Surgical Pathology;Dec2009, Vol. 17 Issue 6, p454 

    The article presents a case study of a 24-year-old male who has repeated history of cellulitis and thrombophlebitis. She died suddenly because of suspected massive pulmonary embolism. The light microscopy showed extensive deposition of birefringent polarizable debris in pulmonary arterioles and...

  • Factor V Leiden Mutation in Venous Thrombosis in Southeast Turkey. Kalkanli, Sevgi; Ayyildiz, Orhan; Tiftik, Naci; Batun, Sabri; Isikdogan, Abdurrahman; Ince, Hakan; Tekes, Selahaddin; Muftuoglu, Ekrem // Angiology;Mar/Apr2006, Vol. 57 Issue 2, p193 

    Venous thrombosis (VT) is a common disease, with an annual incidence in the general population of approximately 1 per 1,000. Factor V Leiden mutation (G1691A) (FVL) is the most common risk factor in venous thrombosis. The prevalence of FVL for thrombosis varies greatly in different regions of...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics